Order Article Reprints

Dank M, Mühl D, Herold M, Hornyák L, Szasz AM, Herold Z. Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer? Journal of Clinical Medicine. 2022; 11(16):4815. https://doi.org/10.3390/jcm11164815

Dank, Magdolna, Dorottya Mühl, Magdolna Herold, Lilla Hornyák, Attila Marcell Szasz, and Zoltan Herold. 2022. "Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?" Journal of Clinical Medicine 11, no. 16: 4815. https://doi.org/10.3390/jcm11164815

Dank, M., Mühl, D., Herold, M., Hornyák, L., Szasz, A. M., & Herold, Z. (2022). Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer? Journal of Clinical Medicine, 11(16), 4815. https://doi.org/10.3390/jcm11164815